Literature DB >> 16813588

Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy.

A Habr-Gama1.   

Abstract

Preoperative chemoradiotherapy is considered by many as the preferred treatment strategy for distal rectal cancer. The observation of complete tumour regression has led to the proposition of nonoperative management of selected patients with complete clinical response (cCR) following treatment. We present results for the treatment of distal rectal cancer during 1991-2005. We have outlined the issues concerning adequate tumour assessment, the definition of complete response, and the advantages and disadvantages of conservative or surgical resection in patients with clinical and radiological evidence of cCR.

Entities:  

Mesh:

Year:  2006        PMID: 16813588     DOI: 10.1111/j.1463-1318.2006.01066.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  30 in total

1.  MRI in predicting curative resection of rectal cancer: new dilemma in multidisciplinary team management.

Authors:  R J Heald; Brian D P O'Neill; Brendan Moran; Gina Brown; Ara W Darzi; Andrew C Wotherspoon; David Cunningham; Diana M Tait
Journal:  BMJ       Date:  2006-10-14

2.  [Open surgery of the rectum].

Authors:  W Hohenberger
Journal:  Chirurg       Date:  2007-08       Impact factor: 0.955

Review 3.  How does genome sequencing impact surgery?

Authors:  Marlies S Reimers; Charla C Engels; Peter J K Kuppen; Cornelis J H van de Velde; Gerrit J Liefers
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

Review 4.  Predicting complete response: is there a role for non-operative management of rectal cancer?

Authors:  T Jonathan Yang; Karyn A Goodman
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 5.  Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy.

Authors:  Valerie M Nelson; Al B Benson
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

6.  miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.

Authors:  Elrasheid A H Kheirelseid; Nicola Miller; Kah Hoong Chang; Catherine Curran; Emer Hennessey; Margaret Sheehan; John Newell; Christophe Lemetre; Graham Balls; Michael J Kerin
Journal:  Int J Colorectal Dis       Date:  2012-08-18       Impact factor: 2.571

Review 7.  Evolving treatment strategies for colorectal cancer: a critical review of current therapeutic options.

Authors:  Daniel C Damin; Anderson R Lazzaron
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

8.  Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer.

Authors:  Sun Gyo Lim; Young Bae Kim; Seung Yeop Oh
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

Review 9.  Advances in radiotherapy in operable rectal cancer.

Authors:  Aravind Suppiah; John E Hartley; John R T Monson
Journal:  Dig Surg       Date:  2009-06-03       Impact factor: 2.588

Review 10.  Recent advances in the treatment of localized rectal cancer.

Authors:  Jean-François Bosset; France Nguyen; Mathieu Bosset; Stéphanie Servagi-Vernat; Benjamin Schipman
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.